Literature DB >> 22143043

Chondrosarcomas of the cervical and cervicothoracic spine: surgical management and long-term clinical outcome.

Xinghai Yang1, Zhipeng Wu, Jianru Xiao, Dapeng Feng, Quan Huang, Wei Zheng, Huajiang Chen, Wen Yuan, Lianshun Jia.   

Abstract

STUDY
DESIGN: A retrospective review study.
OBJECTIVES: To estimate the clinical outcome of various resection protocols in patients with chondrosarcoma (CHS) at the challenging region of cervical and cervicothoracic spine (CCT). SUMMARY OF BACKGROUND DATA: It is challenging to surgically manage CHS of the spine. Although total en-bloc resection has proven to be an ideal treatment, this option is not always feasible in the spine because of the constrains of critical neurovascular structures in the vicinity. Lesions at the CCT region pose even more difficulties, and few large clinical series concerning various protocols and long-term outcomes of these lesions exist at present.
METHODS: Fifteen patients with CHS at the CCT region who underwent surgical management in our institute were retrospectively studied. Twelve piecemeal resections and 3 en-bloc resections were performed. Intraoperative local chemotherapy and postoperative cyberknife radiotherapy were given as adjuvant therapy. Neurologic status, local recurrence, distant metastasis, and treatment-related complications were evaluated.
RESULTS: The mean follow-up time was 58.7 months (median 37 mo; ranging from 18 to 141 mo). Local recurrence was detected in 5 of 5 cases (100%) treated by intracapsular piecemeal resection, and in 1 of 7 cases (14.3%) treated by extracapsular piecemeal resection, whereas no recurrence was found in 3 cases treated by en-bloc resection. Of the 6 recurrent patients, 5 died of disease 24 to 46 months after present surgery, and the remaining patient was alive with disease in the final follow-up. There were no signs of recurrence in the remaining 9 patients.
CONCLUSIONS: For CHS at the CCT region, intralesional piecemeal resection has a poor prognosis and should be avoided. Oncologically, en-bloc resection remains the best form of disease management and should be the primary treatment of choice. For cases in which an uncontaminated en-bloc resection could not be achieved, the extracapsular piecemeal resection with adjuvant therapy including local chemotherapy and cyberknife radiotherapy is an effective and achievable option.

Entities:  

Mesh:

Year:  2012        PMID: 22143043     DOI: 10.1097/BSD.0b013e31820bb085

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  8 in total

1.  Huge myxoid chondrosarcoma expanded into the thoracic cavity with spinal involvement.

Authors:  Ming Lu; Zhongxin Zhou; Zixiong Lei; Haomiao Li; Stefano Boriani
Journal:  Eur Spine J       Date:  2018-07-04       Impact factor: 3.134

2.  Cervical chondrosarcoma- rare malignancy: a case report.

Authors:  Shuaib Merchant; S M Azeem Mohiyuddin; Satish Rudrappa; R P Deo; Sagayaraj A; Lakshmi R Menon
Journal:  Indian J Surg Oncol       Date:  2014-09-14

3.  Cervical subtotal en-bloc spondylectomy of C6 mesenchymal chondrosarcoma.

Authors:  Chang-Hwa Lee; Woo-Kie Min
Journal:  Eur Spine J       Date:  2015-11-10       Impact factor: 3.134

4.  Unilateral lateral mass fixation of cervical spinal low-grade chondrosarcoma with intralesional resection: A case report.

Authors:  Bo Chen; Yan Yang; Liang Chen; Feng Zhou; Huilin Yang
Journal:  Oncol Lett       Date:  2014-03-07       Impact factor: 2.967

Review 5.  Incidence and risk factors of C5 palsy following posterior cervical decompression: a systematic review.

Authors:  Yifei Gu; Peng Cao; Rui Gao; Ye Tian; Lei Liang; Ce Wang; Lili Yang; Wen Yuan
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

6.  Physical Function and Quality of Life After Resection of Mobile Spine Chondrosarcoma.

Authors:  Nuno Rui Paulino Pereira; Stein J Janssen; Nicky Stoop; Stefan Hartveldt; Yen-Lin E Chen; Thomas F DeLaney; Francis J Hornicek; Joseph H Schwab
Journal:  Global Spine J       Date:  2019-02-18

7.  Surgical outcomes and prognostic factors for patients with gastric cancer spinal metastasis.

Authors:  Nanzhe Zhong; Ao Leng; Shaohui He; Minglei Yang; Dan Zhang; Jian Jiao; Wei Xu; Xinghai Yang; Jianru Xiao
Journal:  Cancer Manag Res       Date:  2019-07-24       Impact factor: 3.989

8.  Surgical treatment of metastatic mesenchymal chondrosarcoma to the spine: A case report.

Authors:  Shuzhong Liu; Xi Zhou; An Song; Zhen Huo; Yipeng Wang; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.